GESSEL advised Creotech Instruments on a PLN 481 million public offering

14.07.2026 Case studies Capital Markets Stock market consulting Obtaining financing

GESSEL advised Creotech Instruments on a PLN 481 million public offering

GESSEL advised Creotech Instruments S.A., a Warsaw Stock Exchange listed space technology company, in connection with its public offering of 650,000 Series M shares conducted through an accelerated bookbuilding process. The value of the offering amounted to PLN 481,000,000.00. Series M Shares were admitted to trading on the regulated market operated by the Warsaw Stock Exchange.

The offering attracted strong interest from institutional investors, including international investors. UniCredit acted as Lead Global Coordinator, J.P. Morgan and Trigon acted as Joint Global Coordinators, while BM PKO BP acted as Joint Bookrunner. ccgroup supported the transaction in the areas of equity advisory, investor relations and financial communications.

GESSEL advised Creotech Instruments on all legal aspects of the public offering, including transaction structuring, the preparation and negotiation of transaction documentation, and regulatory advice in connection with the public offering, the share issuance and the admission of the securities to trading.

Lawyers involved in the project

GESSEL advised Creotech Instruments on a PLN 481 million public offering

Krzysztof Marczuk

Partner
Attorney-at-law

Capital Markets

Krzysztof Marczuk
GESSEL advised Creotech Instruments on a PLN 481 million public offering

Michał Wieliński

Managing Associate
Attorney-at-law

Capital Markets | Mergers and acquisitions (M&A) | Corporate law

Michał Wieliński
GESSEL advised Creotech Instruments on a PLN 481 million public offering

Jakub Rowicki

Managing Associate
Advocate

Capital Markets | Mergers and acquisitions (M&A)

Jakub Rowicki
GESSEL advised Creotech Instruments on a PLN 481 million public offering

Magdalena Marczuk

Counsel
Advocate

Capital Markets | Corporate law

Magdalena Marczuk
GESSEL advised Creotech Instruments on a PLN 481 million public offering

Antonina Stępniewska

Associate

Capital Markets

Antonina Stępniewska

You may also like

05.08.2026

GESSEL advised Pure Biologics on a multi-stage transaction comprising a share exchange offer, debt-to-equity conversion and public share offering

GESSEL advised Pure Biologics S.A., a biopharmaceutical company listed on the Warsaw Stock Exchange, on a complex, multi-stage and multi-jurisdictional transaction combi...

Case studies
GESSEL advised Pure Biologics on a multi-stage transaction comprising a share exchange offer, debt-to-equity conversion and public share offering

29.07.2026

GESSEL advised the founders of Clicktrans on the sale of a majority stake to Spire Capital

GESSEL advised Agnieszka Korzeniewska and Michał Brzeziński, the founders of Clicktrans sp. z o.o., one of Europe's largest online marketplaces connecting customers with...

Case studies
GESSEL advised the founders of Clicktrans on the sale of a majority stake to Spire Capital
Wszystkie case studies

Do you want to be up to date?

Subscribe to the newsletter!

GESSEL advised Creotech Instruments on a PLN 481 million public offering